Intracranial hemangioblastoma - A SEER-based analysis 2004-2013

Area of Science:

• Neuro-oncology
• Epidemiology
• Clinical outcomes research

Background:

• Intracranial hemangioblastoma (HB) is a rare central nervous system tumor.
• Limited epidemiological data exist for intracranial HB, necessitating further investigation.

Purpose of the Study:

• To determine the incidence and identify prognostic factors for overall survival (OS) in patients with intracranial hemangioblastoma (HB).

Main Methods:

• Utilized the SEER-18 registry database (2004-2013) to extract data on 1307 intracranial HB cases.
• Analyzed patient demographics, tumor characteristics, treatment modalities (surgery, radiation), and follow-up data.
• Employed Cox proportional hazards models for univariate and multivariate survival analyses.

Main Results:

• The incidence of intracranial HB was 0.153 per 100,000 person-years.
• Univariate analysis identified younger age (<40), absence of radiation, and presence of surgery as positive prognostic factors.
• Multivariate analysis confirmed younger age, Caucasian race, and presence of surgery as significant independent predictors of improved OS.

Conclusions:

• Younger age, Caucasian race, and surgical intervention are key independent prognostic factors for improved survival in intracranial HB patients.
• The study highlights the importance of surgical management but found no significant validation for radiation therapy, potentially due to study limitations.
• Further research is needed to understand the role of radiation and surgical extent in HB outcomes.